Envestnet Asset Management Inc. raised its position in shares of Cigna Group (NYSE:CI - Free Report) by 43.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 676,904 shares of the health services provider's stock after buying an additional 204,285 shares during the period. Envestnet Asset Management Inc. owned about 0.26% of Cigna Group worth $186,609,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in shares of Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock worth $6,461,457,000 after purchasing an additional 840,098 shares during the period. Geode Capital Management LLC increased its holdings in Cigna Group by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider's stock valued at $1,658,055,000 after purchasing an additional 48,474 shares during the period. GQG Partners LLC purchased a new position in Cigna Group during the 2nd quarter valued at about $1,628,918,000. Norges Bank bought a new position in Cigna Group during the 4th quarter valued at approximately $1,019,790,000. Finally, Bank of America Corp DE lifted its stake in Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider's stock worth $848,821,000 after acquiring an additional 256,677 shares during the period. Institutional investors own 86.99% of the company's stock.
Cigna Group Trading Down 1.0%
Cigna Group stock opened at $265.54 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The business's fifty day simple moving average is $280.52 and its two-hundred day simple moving average is $280.32. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company has a market capitalization of $70.16 billion, a price-to-earnings ratio of 10.99, a price-to-earnings-growth ratio of 0.94 and a beta of 0.31.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company's revenue was up 6.7% on a year-over-year basis. During the same period last year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group's dividend payout ratio (DPR) is 25.82%.
Insider Activity at Cigna Group
In related news, insider Nicole Jones sold 2,677 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 22,730 shares of company stock valued at $6,293,359 in the last three months. 0.60% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
CI has been the topic of a number of research reports. Barclays lifted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. Mizuho raised their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. Guggenheim lifted their price objective on Cigna Group from $338.00 to $361.00 and gave the company a "buy" rating in a research report on Friday, July 31st. Robert W. Baird set a $362.00 target price on Cigna Group in a report on Friday, July 31st. Finally, Wall Street Zen lowered Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, September 12th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $337.10.
View Our Latest Stock Analysis on Cigna Group
Cigna Group Company Profile
(
Free Report)
The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.
Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.